Amneal (NYSE: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Our family delivers for yours through a robust U.S. generics business, a growing branded business and deepening portfolios in injectables, biosimilars and select international markets. We’ve bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. And we invest substantially in our people through leadership development and employee well-being programs – all so we can deliver even more value. We are Amneal and We make healthy possible.
Content is for informational purposes only and 3rd party content does not reflect Amneal’s opinions.
Amneal has the right to remove comments that violate another’s copyright or intellectual property, mention an Amneal product, use profanity or are defamatory, promote and solicit for third-party sites, initiatives, or products, or are factually inaccurate or misleading or spam.
Amneal recommends that you consult with your healthcare provider regarding personal health matters. To report a product complaint or adverse event related to an Amneal product, contact Drug Safety at 877-835-5472, option 3 or [email protected] If you are currently experiencing a life-threatening event, please immediately contact 911.
biotechnology, life sciences
Route 53, Outlook, Microsoft Office 365, Amazon AWS, Facebook Login (Connect), Google Font API, Typekit, New Relic, ShareThis, WordPress.org, Google Analytics, Facebook Custom Audiences, Linkedin Marketing Solutions, Twitter Advertising, Apache, Mobile Friendly, Bootstrap Framework, Facebook Widget